Applied DNA Sciences Inc's fundamentals are relatively very healthy, Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at max_target_price.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Applied DNA Sciences Inc's Score
Industry at a Glance
Industry Ranking
152 / 207
Overall Ranking
517 / 4706
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Applied DNA Sciences Inc Highlights
StrengthsRisks
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.43M.
Overvalued
The company’s latest PE is 0.00, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 89.41K shares, increasing 42.30% quarter-over-quarter.
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Ticker SymbolAPDN
CompanyApplied DNA Sciences Inc
CEOShorrock (Clay)
Websitehttps://adnas.com/
FAQs
What is the current price of Applied DNA Sciences Inc (APDN)?
The current price of Applied DNA Sciences Inc (APDN) is 5.620.
What is the symbol of Applied DNA Sciences Inc?
The ticker symbol of Applied DNA Sciences Inc is APDN.
What is the 52-week high of Applied DNA Sciences Inc?
The 52-week high of Applied DNA Sciences Inc is 327.319.
What is the 52-week low of Applied DNA Sciences Inc?
The 52-week low of Applied DNA Sciences Inc is 2.130.
What is the market capitalization of Applied DNA Sciences Inc?
The market capitalization of Applied DNA Sciences Inc is 5.07M.
What is the net income of Applied DNA Sciences Inc?
The net income of Applied DNA Sciences Inc is -7.23M.
Is Applied DNA Sciences Inc (APDN) currently rated as Buy, Hold, or Sell?
According to analysts, Applied DNA Sciences Inc (APDN) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Applied DNA Sciences Inc (APDN)?
The Earnings Per Share (EPS TTM) of Applied DNA Sciences Inc (APDN) is 3601.391.